Fishman Kalman 4
4 · Sensus Healthcare, Inc. · Filed Jun 20, 2018
Insider Transaction Report
Form 4
Fishman Kalman
Chief Technology Officer
Transactions
- Sale
Common Stock
2018-06-18$7.52/sh−5,626$42,308→ 955,023 total - Sale
Common Stock
2018-06-19$7.57/sh−2,626$19,879→ 952,397 total - Sale
Common Stock
2018-06-20$7.52/sh−4,767$35,848→ 947,630 total
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017.
- [F2]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017.
- [F4]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.64. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- [F5]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017.
- [F6]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.65. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.